Tus kws kho mob
QP101-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Dojolvi™ PA
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1841 - 1850 ntawm 4269
Tus kws kho mob
QP100-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor IX PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP95-20 Commercial Pharmacy Benefit Exclusion for Jelmyto®
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP94-20 Commercial Pharmacy Benefit Exclusion for Condylox®, Lyumjev™, Veregen® and Zilxi™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP102-20 Introducing eviCore’s new intelliPath® Technology
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
Upcoming policies effective November 2_ 2020.pdf
Tus kws kho mob
Upcoming policies effective November 30_ 2020.pdf
Tus kws kho mob
P76-20 2021 Renewal Changes Summary for Institutional Providers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2020
Tus kws kho mob
2020 October Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P15R1-20 Update: Change in Requirements for Newborn Precertification Process for Minnesota Health Care Programs
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2020